IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
about
IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
IgM anti-malondialdehyde low d ...... and Biomarker Study 3 (IBIS-3)
@en
IgM anti-malondialdehyde low d ...... istics in the Nordic Diltiazem
@nl
type
label
IgM anti-malondialdehyde low d ...... and Biomarker Study 3 (IBIS-3)
@en
IgM anti-malondialdehyde low d ...... istics in the Nordic Diltiazem
@nl
prefLabel
IgM anti-malondialdehyde low d ...... and Biomarker Study 3 (IBIS-3)
@en
IgM anti-malondialdehyde low d ...... istics in the Nordic Diltiazem
@nl
P2093
P2860
P50
P1433
P1476
IgM anti-malondialdehyde low d ...... and Biomarker Study 3 (IBIS-3)
@en
P2093
Adam Hartley
Artur Fedorowski
Dorian O Haskard
Evelyn Regar
Isabella Kardys
Jurgen M R Ligthart
K Martijn Akkerhuis
Mikhail Caga-Anan
Nicolas van Mieghem
Patrick W Serruys
P2860
P356
10.1016/J.EBIOM.2018.08.023
P407
P577
2018-10-01T00:00:00Z